GSK has announced that it will be expanding its immunology pipeline by acquiring a clinical-stage T cell-engager from ...

Chiesi Group and Oak Hill Bio have announced that the first European patient has been enrolled in a phase 2b study evaluating ...

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and ...

EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to ...

Dermavant Sciences has shared positive long-term results for its plaque psoriasis-approved Vtama (tapinarof) cream in adults and children as young as two years old with atopic dermatitis (AD).

Novo Nordisk has shared promising results from a late-stage study of semaglutide in patients with metabolic dysfunction-associated steatohepatitis (MASH), a progressive metabolic disease that affects ...

Launches have the power to significantly shape an organisation’s trajectory, and ensuring their success is critical for long-term growth. Knowing this, it amazes me how many pharmaceutical ...

After the recent Paralympics, I can’t help but be in awe of the individuals who participated and achieved such amazing feats, despite having everyday challenges most of us can hardly comprehend. It is ...

Major players from across the UK’s health and life sciences sector have responded to the Autumn Budget delivered by Labour Chancellor Rachel Reeves. The Budget is Labour’s first in 14 years and ...

Pharma struggles to differentiate the experiences it provides, missing opportunities to achieve desirable business results and help HCPs at their point of need When a restaurant surprises you by ...

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere vary ...

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous ...